Reclaiming Indigenous systems of healing: experiences of disabled Māori of Māori-centric health service responses in Aotearoa New Zealand during the COVID-19 pandemic.

Publication date: Jan 06, 2025

The impact of the pandemic on Indigenous and disabled people’s access to healthcare has resulted in significant disruptions and has exacerbated longstanding inequitable healthcare service delivery. Research within Aotearoa New Zealand has demonstrated that there has been success in the provision of healthcare by Māori for their community; however, the experiences of tāngata whaikaha Māori, disabled Māori, have yet to be considered by researchers. Underpinned by an empowerment theory and Kaupapa Māori methodology, this research explores the lived realities of tāngata whaikaha Māori or their primary caregivers. Twenty in-depth interviews gathered participants’ lived experiences, and a discursive lens was brought to the narratives of tāngata whaikaha Māori who have accessed, and received, culturally responsive healthcare services during the pandemic. Positive experiences accessing primary and secondary services were associated with Māori-centred healthcare and seamless engagement with support services that were founded upon the active dismantling of structural inequities and the prioritisation of Māori cultural values in their care delivery, inclusive of tino rangatiratanga (sovereignty), and mātauranga Māori (Māori knowledge). This study provides a novel and solid foundation for comprehending how healthcare can be realigned to cater to the requirements of disabled Indigenous populations.

Open Access PDF

Concepts Keywords
Covid COVID-19
Exacerbated Disabled
Healthcare Empowerment methodology
Interviews Healthcare services
Zealand Holistic health services
Indigenous
Kaupapa Māori
Māori

Semantics

Type Source Name
disease MESH COVID-19 pandemic
drug DRUGBANK Spinosad
pathway REACTOME Reproduction
drug DRUGBANK Aspartame
disease IDO host
drug DRUGBANK Coenzyme M
disease IDO country
drug DRUGBANK Polyethylene glycol
disease MESH memory loss
disease IDO history
disease IDO process
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Etoperidone
disease MESH deafness
disease MESH visual impairment
pathway REACTOME Translation
drug DRUGBANK Serine
drug DRUGBANK Methionine
disease MESH chronic conditions
drug DRUGBANK Tretamine
disease IDO blood
disease MESH autism
disease IDO intervention
disease MESH infection
disease MESH emergency
drug DRUGBANK Trestolone
disease MESH loneliness
disease MESH living alone
disease MESH death
disease MESH mental disorders
disease MESH General Health
disease MESH interpersonal violence
disease IDO production

Original Article

(Visited 1 times, 1 visits today)